UPDATE 1-Novartis beats forecasts, sees new drugs fuelling 2018 growth [Reuters]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Reuters
UPDATE 1-Novartis beats forecasts, sees new drugs fuelling 2018 growth | Reuters Reuters Staff 3 Min Read (Adds details, comment from CEO, and dividend info) By John Miller BASEL, Jan 24 (Reuters) - Swiss drugmaker Novartis on Wednesday forecast 2018 operating profit would grow faster than sales as revenue from drugs, including its latest blockbuster Cosentyx, accelerates and the company exits a period when patent losses dented results. Core net income in the fourth quarter of 2017 rose 6 percent to $2.82 billion, Novartis said in a statement, compared with the $2.75 billion average forecast in a Reuters poll. Fourth-quarter sales rose to $12.9 billion, compared to the Reuters poll average of $12.6 billion. The company said 2018 sales would grow at a low-to-mid single-digit percentage range, with core operating profit rising in the mid-to-high single-digits . Novartis Chief Executive Officer Joe Jimenez, who will hand over the reins to Vas Narasimhan on Feb. 1 after eight years at the
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- 20 Countries with the Highest Rates of Stomach Cancer in the World [Yahoo! Finance]Yahoo! Finance
- Novartis AG (NYSE: NVS) had its price target raised by analysts at BMO Capital Markets from $114.00 to $116.00. They now have a "market perform" rating on the stock.MarketBeat
- Roche Sales Decline in Last Quarter of Pandemic Impact [BNN Bloomberg (Canada)]BNN Bloomberg
- Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria [Yahoo! Finance]Yahoo! Finance
- Why Novartis Stock Topped the Market on Tuesday [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/23/24 - Beat
NVS
Sec Filings
- 4/23/24 - Form 6-K
- 2/15/24 - Form S-8
- 2/2/24 - Form SC
- NVS's page on the SEC website